Literature DB >> 19250653

Reining in recurrent Clostridium difficile infection--who's at risk?

Christina M Surawicz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19250653     DOI： 10.1053/j.gastro.2009.02.023

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  5 in total

1.  Protective antibody responses against Clostridium difficile elicited by a DNA vaccine expressing the enzymatic domain of toxin B.

Authors:  Ke Jin; Shixia Wang; Chunhua Zhang; Yanling Xiao; Shan Lu; Zuhu Huang
Journal:  Hum Vaccin Immunother       Date:  2012-11-10       Impact factor: 3.452

2.  Prevalence of diverticulosis in recurrent Clostridium difficile infection.

Authors:  Michael J Lipp; Odelya E Pagovich; David Rabin; Albert D Min; Brett B Bernstein
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

3.  Efficacy of Secondary Prophylaxis With Vancomycin for Preventing Recurrent Clostridium difficile Infections.

Authors:  Alex Carignan; Sébastien Poulin; Philippe Martin; Annie-Claude Labbé; Louis Valiquette; Hamed Al-Bachari; Louis-Philippe Montpetit; Jacques Pépin
Journal:  Am J Gastroenterol       Date:  2016-09-13       Impact factor: 10.864

4.  External validation of two prediction tools for patients at risk for recurrent Clostridioides difficile infection.

Authors:  Tessel M van Rossen; Laura J van Dijk; Martijn W Heymans; Olaf M Dekkers; Christina M J E Vandenbroucke-Grauls; Yvette H van Beurden
Journal:  Therap Adv Gastroenterol       Date:  2021-01-09       Impact factor: 4.409

5.  Outcomes of esophagectomy after chemotherapy with biweekly docetaxel plus cisplatin and fluorouracil for advanced esophageal cancer: a retrospective cohort analysis.

Authors:  Yuji Akiyama; Akira Sasaki; Fumitaka Endo; Haruka Nikai; Satoshi Amano; Akira Umemura; Shigeaki Baba; Takehiro Chiba; Toshimoto Kimura; Takeshi Takahara; Hiroyuki Nitta; Koki Otsuka; Masaru Mizuno; Yusuke Kimura; Keisuke Koeda; Takeshi Iwaya
Journal:  World J Surg Oncol       Date:  2018-07-02       Impact factor: 2.754
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.